Business
Immuron share price shoots 90% higher on potential COVID-19 treatment news – Motley Fool Australia
The Immuron Limited (ASX: IMC) share price has shot 90% higher today following a release regarding the effect of its flagship drug Travelan on Covid-19.
The Immuron Limited (ASX: IMC) share price is up by 89.80% to 46 cents per share this morning on news that Immuron’s product IMM-124E has neutralising activity against the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the virus that causes COVID-19.
This follows on from another positive announcement yesterday that the U.S. Food and Drug Administration (FDA) provided guidance about the development pathway for Immuron’s new oral therapeutic drugs.
What sent Immuron’s share price …
-
General14 hours agoZac Lomax released by Eels for ‘opportunities outside NRL’, fuelling speculation of R360 switch
-
Noosa News22 hours agoPolice urging motorists to drive responsibly, as every life taken is one too many
-
Noosa News20 hours agoSenior constable injured in crash between unmarked police car and stolen vehicle in Pimpama, Queensland
-
Noosa News22 hours agoVictorian farmer to auction father’s vintage tractor collection